Founded in 1966, Aché remains committed to the mission of developing innovative products and services that meet the expectations of healthcare professionals and bring more life to people, wherever they are.

Synonymous with quality, safety and efficacy, Aché’s portfolio consists of 326 brands in 804 SKUs in the prescription, generics, over-the-counter (OTC), dermocosmetics, dermatological products, nutraceuticals, probiotics and biotechnology segments, available to multiple channels (pharmacy chains, independent pharmacies, pharmacy associations, hospitals, clinics and public channel). In all, 25 medical specialties and 142 therapeutic classes are covered.

Aché has four manufacturing sites – Aché (Guarulhos-SP), Biosintética (São Paulo-SP), 50% share in Melcon Indústria Farmacêutica (Anápolis-GO) and the recently acquired Nortis (Londrina-PR). It also holds 25% share in Bionovis, a company dedicated to the research and development of biotechnologicals, through joint venture with three other Brazilian pharmaceutical companies. In March 2016, Aché acquired the chemical-pharmaceutical division of Laboratório Tiaraju, specialized in phytomedicines and functional foods.

With a structured internationalization plan, we currently have licensing agreements that ensure the sale of 32 drugs in 57 presentations to 25 countries in Americas, Middle East, Africa and Asia.

Aché has 4.7 thousand employees committed to the continuous generation of value for patients, physicians, business partners and the entire society. In order to maintain the close relationship with healthcare professionals and points of sale through face-to-face and virtual visits, the Company has more than 2 thousand employees active in the Demand and Sales Generation Forces, spread throughout Brazil.

Aché, more life for you.

Learn more about our history in the time line below or in our institucional video